Medical Developments International Limited announced that it has reached agreement with Mundipharma Pty Ltd. (Mundipharma) for the exclusive distribution rights of Penthrox® in Australia. Mundipharma will provide their sales force and marketing experience and MVP will continue to maintain relationships within the key ambulance channel and support Mundipharma with their marketing endeavours. The agreement contains minimum volumes which guarantee current turnover in Australia but with significant forecast upside.